How should investors evaluate Acadia Pharmaceuticals Inc (NASDAQ:ACAD)?
Stocks of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) traded higher last session on Wall Street, down -15.83% to $21.53. According to the data, Acadia Pharmaceuticals Inc (NASDAQ:ACAD) has 16 analysts covering its stock. The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $42.00 and […]
The shares of ACADIA Pharmaceuticals Inc. (ACAD) have recorded the market capitalization of 4.72B
The stock of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) last traded at $29.04, up 0.07% from the previous session. ACAD stock price is now 13.18% away from the 50-day moving average and 46.52% away from the 200-day moving average. The market capitalization of the company currently stands at $4.72B. With the price target maintained at $22, Guggenheim […]
Do futuristic bulls still own ACADIA Pharmaceuticals Inc. [ACAD] stock?
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares traded 4.02% higher at $25.86 on Wall Street last session. In accordance with the data, 18 analysts cover ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $36.00 and a low of $12.00, […]
